Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP494531.RAk_OcsPmz3y-arJbxhOoP_6zNY7wSPTtph9BOJ20u0L4130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494531.RAk_OcsPmz3y-arJbxhOoP_6zNY7wSPTtph9BOJ20u0L4130_provenance.
• NP638690.RAnmFn46eVLg9-MtVmTb7iyK1Z8pjeFeSXRSGTp4qKZmc130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638690.RAnmFn46eVLg9-MtVmTb7iyK1Z8pjeFeSXRSGTp4qKZmc130_provenance.
• NP801328.RAsZJKdszIpWaGKI8sTTWzNJQuaSxjXmRdpIXyGuwvWF0130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801328.RAsZJKdszIpWaGKI8sTTWzNJQuaSxjXmRdpIXyGuwvWF0130_provenance.
• NP792785.RAW7rrfaXfp9gJJOLza5zdi_ksLaWhilFskhQ0KrpxGDM130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792785.RAW7rrfaXfp9gJJOLza5zdi_ksLaWhilFskhQ0KrpxGDM130_provenance.
• NP299868.RA_pIlYijKaHCzh2MLWbGweUlvAQdm9vkGCjR6qZHW5yw130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299868.RA_pIlYijKaHCzh2MLWbGweUlvAQdm9vkGCjR6qZHW5yw130_provenance.
• NP650405.RA0rYRfixn2s4DZeRGSu7yAypbC1MJDmIjauZhiJCw8uU130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650405.RA0rYRfixn2s4DZeRGSu7yAypbC1MJDmIjauZhiJCw8uU130_provenance.
• NP468426.RAfTuZ6POTRGfNhcZXr7OXUytlTKmLoUjJDLKdHkXk87U130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468426.RAfTuZ6POTRGfNhcZXr7OXUytlTKmLoUjJDLKdHkXk87U130_provenance.
• NP468780.RAfvMF9gLLeDi9yCKzeiNWO_8uNapcyGybCRmFUTwLH2I130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468780.RAfvMF9gLLeDi9yCKzeiNWO_8uNapcyGybCRmFUTwLH2I130_provenance.
• NP796861.RAzlpSCoLvwpM2HM917n4mUzLbaWx3M-JpZRZeIFvOl68130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796861.RAzlpSCoLvwpM2HM917n4mUzLbaWx3M-JpZRZeIFvOl68130_provenance.
• assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP757833.RAoZpV8-HIG2MhQML1Ge-dQxoxGxxjBFuuuG3Mk1HV1fw130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757833.RAoZpV8-HIG2MhQML1Ge-dQxoxGxxjBFuuuG3Mk1HV1fw130_provenance.
• NP579828.RASyhB5QPJIUr9m4EaoCq88RuytOh4EAk369pxozpSqxQ130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579828.RASyhB5QPJIUr9m4EaoCq88RuytOh4EAk369pxozpSqxQ130_provenance.
• NP812270.RAoqEys7EXdlSvUrzadESy5-ZMEWX82sHEPMDQXPNkY0o130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812270.RAoqEys7EXdlSvUrzadESy5-ZMEWX82sHEPMDQXPNkY0o130_provenance.
• NP579825.RAgay7bQp_3nq8XaqSyM1ehx8bFBruPYXPDWwMA5hunNQ130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579825.RAgay7bQp_3nq8XaqSyM1ehx8bFBruPYXPDWwMA5hunNQ130_provenance.
• NP579827.RAGLsuzh6ZGmYYR0h-t7Z_Yub-dkW_Lv57VHBxAtLddak130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579827.RAGLsuzh6ZGmYYR0h-t7Z_Yub-dkW_Lv57VHBxAtLddak130_provenance.
• NP579824.RA0cGgFqo8gx7c-qyJKmpDBEX1wcQWHWKtu9NsK07qgBY130_assertion description "[In conclusion, our findings indicate that (1) HSP induction protects against atrial tachycardia-induced remodeling, (2) the protective effect in HL-1 myocytes requires HSP27 induction and phosphorylation, and (3) the orally administered HSP inducer GGA protects against AF in a clinically relevant animal model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579824.RA0cGgFqo8gx7c-qyJKmpDBEX1wcQWHWKtu9NsK07qgBY130_provenance.